Mitral regurgitation is a leading cause of valvular heart disease in Western countries. Transcatheter mitral valve replacement (TMVR) has emerged as a potential therapeutic option for patients with severe mitral disease who are at high risk for conventional surgery. Watch these presentations to find out about...

View a replay of the Jon DeHaan Foundation Award Ceremony, during which David Kuraguntla and Domenico D’Amario receive rewards for their innovative developments in cardiovascular medicine!

Learn more about the Jon DeHaan Foundation: https://www.jondehaanfoundation.org/

This session was originally presented during EuroPCR 2021.

This session will provide you with 90-day outcomes of a novel no-implant interatrial shunt first in human trial, six-month outcomes of transcatheter LV restoration in heart failure patients, and mid-term results of hybrid LV reconstruction in ischemic HFrEF.

Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...

Discover the replay of this PCR Webinar on valve durability with N. Dumonteil, G. Tarantini and N. Van Mieghem

Discover the replay of this PCR Webinar on bifurcation with B. Chevalier, G. Toth and G. Stankovic

Watch the replay of this PCR Webinar with G. Stankovic, D. Hildick-Smith, M-C. Morice and A. Neylon.

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology / World Heart Federation 2023 Scientific Sessions #ACC23 #WCCardio.

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

The normal aortic valve is trifoliate, the three leaflets form the aortic valve and provide its main sealing mechanism. Find out more about the anatomy as illustrated in the TAVI Atlas.

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Alex Sticchi provides his take on the results of the TRI.FR trial presented by Erwan Donal at the ESC Congress 2024 in London.

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...